Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on o Chlorophenylglycine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118028274A details a novel acylase mutant enhancing (S)-o-chlorophenylglycine synthesis. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114507650B reveals a mutant enzyme boosting yield and purity for Clopidogrel intermediates, ensuring stable supply chains and reduced manufacturing costs for global buyers.
Patent CN114507650A details a high-efficiency biocatalytic route for Clopidogrel intermediates, offering superior stereoselectivity and substrate tolerance for scalable API manufacturing.
Patent CN114685300A reveals a novel synthesis for o-chlorophenylglycine, eliminating red oil by-products and decolorization steps for superior cost efficiency and supply reliability.